Thomas Jeffrey Hendrix, MD | |
1515 N Madison Ave, Anderson, IN 46011-3453 | |
(765) 298-4242 | |
Not Available |
Full Name | Thomas Jeffrey Hendrix |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 17 Years |
Location | 1515 N Madison Ave, Anderson, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982870218 | NPI | - | NPPES |
000000839618 | Other | IN | ANTHEM |
P01291570 | Other | IN | RAILROAD MEDICARE |
200985530 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 01068401A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lakewood Ranch Medical Center | Bradenton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Accountable Inpatient Medicine | 5597090274 | 43 |
Mda Anesthesia Llc | 2668809914 | 12 |
News Archive
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.
Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
New research shows that women regularly screened for ovarian cancer are just as likely to die from the disease. This comes as no surprise as there are still no adequate detection methods, says Ovarian Cancer Australia. Of the 1,200 Australian women diagnosed with ovarian cancer each year, 800 die, often because it is diagnosed too late to be treated.
› Verified 2 days ago
Entity Name | Accountable Inpatient Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659936870 PECOS PAC ID: 5597090274 Enrollment ID: O20190717003010 |
News Archive
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.
Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
New research shows that women regularly screened for ovarian cancer are just as likely to die from the disease. This comes as no surprise as there are still no adequate detection methods, says Ovarian Cancer Australia. Of the 1,200 Australian women diagnosed with ovarian cancer each year, 800 die, often because it is diagnosed too late to be treated.
› Verified 2 days ago
Entity Name | Truepartners Lakewood Inpatient Specialist |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700438504 PECOS PAC ID: 8527399286 Enrollment ID: O20191010000202 |
News Archive
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.
Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
New research shows that women regularly screened for ovarian cancer are just as likely to die from the disease. This comes as no surprise as there are still no adequate detection methods, says Ovarian Cancer Australia. Of the 1,200 Australian women diagnosed with ovarian cancer each year, 800 die, often because it is diagnosed too late to be treated.
› Verified 2 days ago
Entity Name | Mda Anesthesia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336784115 PECOS PAC ID: 2668809914 Enrollment ID: O20200226000293 |
News Archive
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.
Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
New research shows that women regularly screened for ovarian cancer are just as likely to die from the disease. This comes as no surprise as there are still no adequate detection methods, says Ovarian Cancer Australia. Of the 1,200 Australian women diagnosed with ovarian cancer each year, 800 die, often because it is diagnosed too late to be treated.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas Jeffrey Hendrix, MD 6626 E 75th St, Suite 500, Indianapolis, IN 46250-2805 Ph: () - | Thomas Jeffrey Hendrix, MD 1515 N Madison Ave, Anderson, IN 46011-3453 Ph: (765) 298-4242 |
News Archive
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.
Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma.
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
New research shows that women regularly screened for ovarian cancer are just as likely to die from the disease. This comes as no surprise as there are still no adequate detection methods, says Ovarian Cancer Australia. Of the 1,200 Australian women diagnosed with ovarian cancer each year, 800 die, often because it is diagnosed too late to be treated.
› Verified 2 days ago
Mark Randall Jennings, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Dr. Dalwinderpal Singh Samra, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave., Anderson, IN 46016 Phone: 609-694-8566 | |
Ubaidullah Sharief, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 100, Anderson, IN 46016 Phone: 765-646-8509 | |
Adam L Greene, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Chad Michael Feldman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Dr. Edgardo Manuel Flores Anticona, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 110, Anderson, IN 46016 Phone: 765-643-6012 Fax: 765-646-9054 | |
Kristine M Rea, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 212, Anderson, IN 46016 Phone: 765-648-4138 |